Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cowealth Medical Holding CoROCO:4745 +0.70%49 PS Ratio is 0.38 as of Jul. 19, 2026, which is 22% below its 10-year median of 0.49. GuruFocus rates ROCO:4745 with a GF Score™ of 49/100 and a GF Value™ of NT$13.07 (Fairly Valued). The stock has 6 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Cowealth Medical Holding Co ranks better than 93.91% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Cowealth Medical Holding Co's share price is NT$14.35.
Cowealth Medical Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$38.00. Hence, Cowealth Medical Holding Co's PS Ratio for today is 0.38.
The historical rank and industry rank for Cowealth Medical Holding Co's PS Ratio or its related term are showing as below:
ROCO:4745'
s PS Ratio Range Over the Past 10 Years
Min: 0.33 Med: 0.49 Max: 1.41
Current: 0.38
During the past 13 years, Cowealth Medical Holding Co's highest PS Ratio was 1.41. The lowest was 0.33. And the median was 0.49.
ROCO:4745's PS Ratio is ranked better than 93.91% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.855
vs ROCO:4745: 0.38
Cowealth Medical Holding Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Cowealth Medical Holding Co was -29.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -19.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -8.50% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 3.40% per year.
During the past 13 years, Cowealth Medical Holding Co's highest 3-Year average Revenue per Share Growth Rate was 34.10% per year. The lowest was -19.30% per year. And the median was 7.15% per year.
Back to Basics: PS Ratio
Cowealth Medical Holding Co (ROCO:4745) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Cowealth Medical Holding Co PS Ratio Related Terms
Cowealth Medical Holding Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cowealth Medical Holding Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Cowealth Medical Holding Co's Share Price of today is NT$14.35. Cowealth Medical Holding Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$38.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Cowealth Medical Holding Co (ROCO:4745) has a PS Ratio of 0.38 as of Jul. 19, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cowealth Medical Holding Co and its competitors. This is 22% below median its historical median of 0.49. Over the past decade, Cowealth Medical Holding Co's PS Ratio has ranged from 0.33 to 1.41. According to the industry distribution chart, Cowealth Medical Holding Co ranks #49 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 6.1%.
Is Cowealth Medical Holding Co's PS Ratio too high?
Cowealth Medical Holding Co's current PS Ratio of 0.38 is 22% below median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 1.41. The Medical Devices & Instruments industry median PS Ratio is 2.86. Cowealth Medical Holding Co's value of 0.38 is 86.7% below this industry median. Based on the distribution chart, Cowealth Medical Holding Co ranks #49 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cowealth Medical Holding Co has a GF Score™ of 49/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #49 out of 804 companies for PS Ratio. This places Cowealth Medical Holding Co in the top 6% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.86. Cowealth Medical Holding Co's value of 0.38 is 86.7% below this benchmark. Historically, Cowealth Medical Holding Co's own PS Ratio has ranged from 0.33 to 1.41 over the past decade. While the company's 10-year median is 0.49 vs. the industry median of 2.86, Cowealth Medical Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cowealth Medical Holding Co's current PS Ratio of 0.38 is 86.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Cowealth Medical Holding Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cowealth Medical Holding Co's current PS Ratio is 0.38, which is 22% below median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.07, compared to a current price of NT$14.35 — trading 9.8% above its estimated fair value. The current PS Ratio is 0.38, which is 22% below median its 10-year median of 0.49 and 86.7% below the Medical Devices & Instruments industry median of 2.86. Cowealth Medical Holding Co's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current PS Ratio is 0.38 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued.
The current stock price of NT$14.35 is trading 9.8% above its estimated GF Value™ of NT$13.07.
GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.
Key valuation signals for ROCO:4745:
PS Ratio: 0.38 (22% below median its 10-year median of 0.49)
GF Value™: NT$13.07 vs. price of NT$14.35 (9.8% above fair value)
Industry Position: 86.7% below the Medical Devices & Instruments median (#49 of 804)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
49GF Score
Get the complete analysis for ROCO:4745
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
